Description
Borviz 2.5mg Injection 1’s is a potent pharmaceutical solution designed for targeted cancer care. Each injection contains the active ingredient Bortezomib, a proteasome inhibitor, which plays a crucial role in managing multiple myeloma, a type of cancer that affects white blood cells. This medication is administered intramuscularly or subcutaneously, and its primary therapeutic use is to slow the progression of multiple myeloma by inhibiting the growth of cancer cells. Borviz 2.5mg Injection 1’s is a vital tool in the arsenal of treatments for multiple myeloma, offering hope and support for those battling this complex disease.
Reviews
There are no reviews yet.